ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 728

Nailfold Videocapillaroscopy Patterns and Digital Occlusive Arterial Disease on Laser Doppler Flowmetry Strongly Predicts the Diagnosis of Systemic Sclerosis and Other Connective Tissue Diseases

Yasser Radwan1, Tina Gunderson 2, Cynthia Crowson 3, David Liedl 4, Alicia Hinze 1, Kenneth Warrington 4, Paul Wennberg 4 and Ashima Makol 1, 1Mayo Clinic Minnesota, rochester, MN, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic Rochester, Rochester, 4Mayo Clinic Rochester, rochester, MN

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: connective tissue diseases and Raynaud's phenomenon, Doppler ultrasound, nailfold capillaroscopy, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Vasculopathy is a key feature of systemic sclerosis (SSc), a chronic autoimmune disease associated with widespread fibrosis and internal organ dysfunction. While structural abnormalities of the microcirculation are best seen on nailfold videocapillaroscopy (NVC), laser doppler flowmetry (LDF) with a thermal challenge is a highly accurate, safe, and noninvasive means to detect digital occlusive arterial disease (DOAD) with a sensitivity and specificity of >90% (1).We reviewed NVC patterns and DOAD on LDF in a cohort of patients referred to our NVC clinic for evaluation of Raynaud’s or suspected connective tissue disease (CTD), their correlation, and their predictive value in diagnosing SSc or any CTD.

Methods: Medical records of patients that underwent NVC and LDF at our institution between 1/1/2017 and 3/31/2019 were retrospectively reviewed. NVC results were classified as normal or abnormal (non-specific or SSc specific pattern- early, active or late). Presence or absence of DOAD on LDF was abstracted. Clinical diagnosis of CTDs and fulfilment of ACR/EULAR 2013 SSc classification criteria and Very early diagnosis of Systemic sclerosis (VEDOSS) criteria was ascertained.

Results: 190 patients (mean age 46 ± 15 yrs, 81% females, 93% white) underwent NVC and LDF during the study period. NVC was normal in 102 (54%) patients and abnormal in 88 (Non-specific 31[35%], SSc pattern 57[65%]).

On LDF with thermal challenge, 78% of patients had vasospasm and DOAD was noted in 30 (16%) patients. Among 30 patients with DOAD, a CTD was diagnosed in 24 (80%), of which 17 (57%) met SSc criteria.

Among the 30 patients with DOAD, 24 (80%) had abnormal NVC patterns with SSc NVC pattern in 18 (60%) (3 early, 8 active and 7 late). Among the 160 patients without DOAD, 93 (58%) did not have any CTD and NVC was normal in 96 (60%) of the patients.

SSc NVC pattern was strongly predictive of meeting VEDOSS (positive predictive value (PPV):84%) and diagnosis of CTDs (PPV: 77%). Addition of DOAD to SSc NVC pattern increased the likelihood of meeting SSc criteria (PPV increased from 46% to 83%), diagnosis of CTDs (PPV increased from 77% to 100%) and slightly improved fulfillment of VEDOSS.

Having normal NVC was associated with very low likelihood of SSc diagnosis (negative predictive value (NPV): 98%) and VEDOSS (NPV: 91%), but did not help significantly in exclusion of other CTDs (NPV: 66%). Using a composite predictor of abnormal NVC or DOAD did not significantly change the NPV for excluding SSc or CTDs, compared to NVC alone (Table ).

Conclusion: Our study suggests that the presence of DOAD on LDF in patients with RP and/or suspected CTD is strongly associated with presence of an underlying CTD, particularly SSc. Patients with DOAD and SSc, are more likely to have an ‘active or late’ SSc pattern on NVC rather than ‘early’. A SSc pattern NVC in combination with DOAD is very strongly predictive of an underlying CTD, with SSc in >80% cases. A normal NVC virtually excludes the presence of SSc, but not other CTDs. Adding LDF to NVC, can further increase the predictive value of NVC alone for CTD diagnosis.

Reference

(1) Mahe G et al. J Vasc Surg. 2014 Apr;59(4):1051-1057.e1

Table. Sensitivity, specificity, positive and negative predictive values of nailfold videocapillaroscopy -NVC- alone and in association with digital occlusive arterial disease -DOAD- on laser doppler flowmetry -LDF- in predicting systemic sclerosis -SSc- and connective tissue disaeses -CTDs-


Disclosure: Y. Radwan, None; T. Gunderson, None; C. Crowson, Crescendo Bioscience, 5, Crescendo BioScience Inc., 5, Crescendo Bioscience Inc., 5, Crescendo Biosciences inc., 5, Pfizer, 2; D. Liedl, None; A. Hinze, None; K. Warrington, Eli Lilly, 2, GlaxoSmithKline, 2, roche, 2, 8, Roche, 2, 5, 8, Sanofi, 5, sanofi, 5; P. Wennberg, None; A. Makol, None.

To cite this abstract in AMA style:

Radwan Y, Gunderson T, Crowson C, Liedl D, Hinze A, Warrington K, Wennberg P, Makol A. Nailfold Videocapillaroscopy Patterns and Digital Occlusive Arterial Disease on Laser Doppler Flowmetry Strongly Predicts the Diagnosis of Systemic Sclerosis and Other Connective Tissue Diseases [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/nailfold-videocapillaroscopy-patterns-and-digital-occlusive-arterial-disease-on-laser-doppler-flowmetry-strongly-predicts-the-diagnosis-of-systemic-sclerosis-and-other-connective-tissue-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nailfold-videocapillaroscopy-patterns-and-digital-occlusive-arterial-disease-on-laser-doppler-flowmetry-strongly-predicts-the-diagnosis-of-systemic-sclerosis-and-other-connective-tissue-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology